Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

Reconstruction of a Unilateral Alveolar Cleft Using a Customized Allogenic Bone Block and Subsequent Dental Implant Placement in an Adult Patient.

Blume O, Back M, Born T, Donkiewicz P.

J Oral Maxillofac Surg. 2019 Jun 7. pii: S0278-2391(19)30552-X. doi: 10.1016/j.joms.2019.05.021. [Epub ahead of print]

PMID:
31276656
2.

Reflecting on survivorship outcomes to aid initial decision making in patients treated for IDH-mutated anaplastic glioma.

Back MF, Jayamanne D, Back E, Kastelan M, Khasraw M, Wong M, Brown C, Wheeler H.

Cancer. 2019 Jun 28. doi: 10.1002/cncr.32352. [Epub ahead of print]

PMID:
31251406
3.

Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma.

Cuncannon M, Wong M, Jayamanne D, Guo L, Cove N, Wheeler H, Back M.

BMC Cancer. 2019 May 14;19(1):445. doi: 10.1186/s12885-019-5678-1.

4.

Focal radiation therapy for limited brain metastases is associated with high rates of local control and low subsequent whole brain radiation therapy.

Or M, Jayamanne D, Guo L, Stevens M, Parkinson J, Cook R, Little N, Back M.

ANZ J Surg. 2019 Apr;89(4):418-422. doi: 10.1111/ans.15040. Epub 2019 Mar 5.

PMID:
30836451
5.

Bilateral maxillary augmentation using CAD/CAM manufactured allogenic bone blocks for restoration of congenitally missing teeth: A case report.

Blume O, Donkiewicz P, Back M, Born T.

J Esthet Restor Dent. 2019 May;31(3):171-178. doi: 10.1111/jerd.12454. Epub 2019 Feb 12.

PMID:
30756449
6.

Impact of Radiation Target Volume on Health-Related Quality of Life in Patients With Low-Grade Glioma in the 2-Year Period Post Treatment: A Secondary Analysis of the EORTC 22033-26033.

Dirven L, Reijneveld JC, Taphoorn MJB, Coens C, El-Badawy SA, Tzuk-Shina T, Bravo-Marques J, Back M, Stalpers LJA, Stupp R, Baumert BG, Seidel C.

Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):90-100. doi: 10.1016/j.ijrobp.2019.01.003. Epub 2019 Feb 2.

PMID:
30716525
7.

Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management.

Back M, Jayamanne DT, Brazier D, Newey A, Bailey D, Schembri GP, Hsiao E, Khasraw M, Wong M, Kastelan M, Guo L, Clarke S, Wheeler H.

J Med Imaging Radiat Oncol. 2019 Apr;63(2):272-280. doi: 10.1111/1754-9485.12850. Epub 2019 Jan 24.

PMID:
30677248
8.

Tumour volume reduction following PET guided intensity modulated radiation therapy and temozolomide in IDH mutated anaplastic glioma.

Back M, Jayamanne D, Brazier D, Bailey D, Hsiao E, Guo L, Wheeler H.

J Clin Neurosci. 2019 Jan;59:68-74. doi: 10.1016/j.jocn.2018.11.005. Epub 2018 Nov 14.

PMID:
30446361
9.

Optimising Outcomes for Glioblastoma through Subspecialisation in a Regional Cancer Centre.

Back M, Jayamanne D, Cove N, Wheeler H, Khasraw M, Guo L, Back J, Wong M.

Brain Sci. 2018 Oct 15;8(10). pii: E186. doi: 10.3390/brainsci8100186.

10.

FET PET in the evaluation of indeterminate brain lesions on MRI: Differentiating glioma from other non-neoplastic causes - A pilot study.

Chan DL, Hsiao E, Schembri G, Bailey DL, Roach PJ, Lee A, Jayamanne D, Ghasemzadeh M, Hayes A, Cook R, Parkinson J, Drummond JP, Ibbett I, Wheeler HR, Back M.

J Clin Neurosci. 2018 Dec;58:130-135. doi: 10.1016/j.jocn.2018.09.009. Epub 2018 Sep 19.

PMID:
30243602
11.

Radiation, inflammation and the immune response in cancer.

McKelvey KJ, Hudson AL, Back M, Eade T, Diakos CI.

Mamm Genome. 2018 Dec;29(11-12):843-865. doi: 10.1007/s00335-018-9777-0. Epub 2018 Sep 3. Review.

12.

Predicting patterns of failure in temporal lobe GBMs: possible implications on radiotherapy treatment portals.

Jayamanne D, Wheeler H, Brazier D, Newey A, Kastelan M, Guo L, Back M.

Radiat Oncol. 2018 Jul 20;13(1):133. doi: 10.1186/s13014-018-1078-y.

13.

Treatment of a bilaterally severely resorbed posterior mandible due to early tooth loss by Guided Bone Regeneration using customized allogeneic bone blocks: A case report with 24 months follow-up data.

Blume O, Back M, Born T, Smeets R, Jung O, Barbeck M.

J Esthet Restor Dent. 2018 Nov;30(6):474-479. doi: 10.1111/jerd.12388. Epub 2018 Jun 19.

PMID:
29920915
14.

Accreditation Standard Guideline Initiative for Tai Chi and Qigong Instructors and Training Institutions.

Oh B, Yeung A, Klein P, Larkey L, Ee C, Zaslawski C, Knobf T, Payne P, Stener-Victorin E, Lee R, Choi W, Chun M, Bonucci M, Lang HD, Pavlakis N, Boyle F, Clarke S, Back M, Yang P, Wei Y, Guo X, Weng CD, Irwin MR, Elfiky AA, Rosenthal D.

Medicines (Basel). 2018 Jun 8;5(2). pii: E51. doi: 10.3390/medicines5020051.

15.

Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.

Hayes AR, Jayamanne D, Hsiao E, Schembri GP, Bailey DL, Roach PJ, Khasraw M, Newey A, Wheeler HR, Back M.

Pract Radiat Oncol. 2018 Jul - Aug;8(4):230-238. doi: 10.1016/j.prro.2018.01.006. Epub 2018 Jan 31.

PMID:
29730279
16.

Convergent priorities and tensions: a qualitative study of the integration of complementary and alternative therapies with conventional cancer treatment.

River J, McKenzie H, Levy D, Pavlakis N, Back M, Oh B.

Support Care Cancer. 2018 Jun;26(6):1791-1797. doi: 10.1007/s00520-017-4021-0. Epub 2017 Dec 16.

PMID:
29249059
17.

Health and well-being benefits of spending time in forests: systematic review.

Oh B, Lee KJ, Zaslawski C, Yeung A, Rosenthal D, Larkey L, Back M.

Environ Health Prev Med. 2017 Oct 18;22(1):71. doi: 10.1186/s12199-017-0677-9. Review.

18.

Acupuncture in Oncology: The Effectiveness of Acupuncture May Not Depend on Needle Retention Duration.

Oh B, Eade T, Kneebone A, Hruby G, Lamoury G, Pavlakis N, Clarke S, Zaslawski C, Marr I, Costa D, Back M.

Integr Cancer Ther. 2018 Jun;17(2):458-466. doi: 10.1177/1534735417734912. Epub 2017 Nov 2.

19.

Treatment of Severely Resorbed Maxilla Due to Peri-Implantitis by Guided Bone Regeneration Using a Customized Allogenic Bone Block: A Case Report.

Blume O, Hoffmann L, Donkiewicz P, Wenisch S, Back M, Franke J, Schnettler R, Barbeck M.

Materials (Basel). 2017 Oct 21;10(10). pii: E1213. doi: 10.3390/ma10101213.

20.

Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI.

Jaymanne DT, Kaushal S, Chan D, Schembri G, Brazier D, Bailey D, Wheeler H, Back M.

J Med Imaging Radiat Oncol. 2018 Feb;62(1):122-127. doi: 10.1111/1754-9485.12676. Epub 2017 Oct 5.

PMID:
28980392

Supplemental Content

Loading ...
Support Center